Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03508960

Chinese EOPD Registry

The Chinese Early-onset Parkinson's Disease Registry

Status
Recruiting
Phase
Study type
Observational
Enrollment
3,000 (estimated)
Sponsor
Xiangya Hospital of Central South University · Academic / Other
Sex
All
Age
50 Years
Healthy volunteers
Not accepted

Summary

The purpose of the Chinese Early-onst Parkinson's disease Registry (CEOPDR) is to develop a database of persons with early-onset Parkinson's disease (EOPD) in China.

Detailed description

Parkinson's disease (PD) is the second most common disorder among degenerative neurological disease. Early-onset PD (EOPD) has its unique clinical feature and genetic basis.Investigators aim to establish a database of EOPD,and characterize the clinical feature, genetic basis, environmental factors and their interactions EOPD in China. Method: 1. Clinical feature will be measured by scales and neurological tests.Standard scales includes: Unified Parkinson's Disease Rating Scale(UPDRS), Hoehn-Yahr stages, NMSS, MMSE, PDSS(Parkinson disease sleep scales),Rapid Eye Movement Sleep Behaviour Disorder Questionnaire(RBDQ-HK),ESS(Epworth Sleepiness Scale),Rome III functional constipation scale,SCOPA-AUT (the Scale for Outcomes in PD for Autonomic Symptoms),PFS(Parkinson Fatigue Scale),CH-RLSq,Hyposmia rating scale(HRS)HAMILT depression scale,the 39-item Parkinson's Disease Questionnaire(PDQ-39),Freezing of gait scale(FOG),dyskinesia related scales, Wearing-off scale(WO) 2. Peripheral blood from patients was collected for whole exome sequencing. 3. The environmental factors are explored by questionnaires including smoking,drinking, pesticide and heavy metals.

Conditions

Timeline

Start date
2017-02-01
Primary completion
2027-02-01
Completion
2027-02-01
First posted
2018-04-26
Last updated
2018-05-11

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03508960. Inclusion in this directory is not an endorsement.